ADHERENCE TO THE USE OF PROPHYLATIC PENICILLIN AND ASSOCIATED COSTS IN SICKLE CELL DISEASE
Lido
1639
Vezesque se leu este artigo
760
Total PDF
879
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 16 | 15 | 31 |
| 2025 5 | 31 | 13 | 44 |
| 2025 4 | 25 | 9 | 34 |
| 2025 3 | 40 | 10 | 50 |
| 2025 2 | 23 | 16 | 39 |
| 2025 1 | 21 | 11 | 32 |
| 2024 12 | 21 | 15 | 36 |
| 2024 11 | 29 | 19 | 48 |
| 2024 10 | 23 | 15 | 38 |
| 2024 9 | 26 | 10 | 36 |
| 2024 8 | 27 | 23 | 50 |
| 2024 7 | 17 | 23 | 40 |
| 2024 6 | 26 | 20 | 46 |
| 2024 5 | 26 | 32 | 58 |
| 2024 4 | 24 | 13 | 37 |
| 2024 3 | 41 | 20 | 61 |
| 2024 2 | 33 | 15 | 48 |
| 2024 1 | 16 | 18 | 34 |
| 2023 12 | 18 | 23 | 41 |
| 2023 11 | 30 | 18 | 48 |
| 2023 10 | 18 | 18 | 36 |
| 2023 9 | 20 | 31 | 51 |
| 2023 8 | 18 | 17 | 35 |
| 2023 7 | 15 | 3 | 18 |
| 2023 6 | 18 | 9 | 27 |
| 2023 5 | 19 | 14 | 33 |
| 2023 4 | 10 | 10 | 20 |
| 2023 3 | 12 | 12 | 24 |
| 2023 2 | 10 | 15 | 25 |
| 2023 1 | 12 | 6 | 18 |
| 2022 12 | 14 | 18 | 32 |
| 2022 11 | 18 | 21 | 39 |
| 2022 10 | 16 | 20 | 36 |
| 2022 9 | 18 | 15 | 33 |
| 2022 8 | 9 | 16 | 25 |
| 2022 7 | 14 | 23 | 37 |
| 2022 6 | 11 | 20 | 31 |
| 2022 5 | 25 | 23 | 48 |
| 2022 4 | 9 | 20 | 29 |
| 2022 3 | 14 | 19 | 33 |
| 2022 2 | 12 | 15 | 27 |
| 2021 1 | 10 | 13 | 23 |
| 2021 12 | 13 | 24 | 37 |
| 2021 11 | 12 | 21 | 33 |
| 2021 10 | 19 | 19 | 38 |
Mostrar tudo
